| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |